What is it about?
This is study about survival of MDR-TB patients who were commenced on second-line ATI-TB drugs. Though a progress has been made in combating the burden of multi-drug resistance tuberculosis (MDR-TB), it remained the major public health threat. This study found 11% of deaths with the overall incidence density of death was 11.99, 95% CI [7.89–18.21] per 100,000person-year.
Featured Image
Why is it important?
This finding is very alarming for the all responsible bodies working in the area of MDR-TB.
Perspectives
The study is about to show the impact of MDR-TB in LMICs. It could have a critical implication to drew the attention of researchers, policy makers and funding agencies.
TESHALE AYELE
Addis Ababa University
Read the Original
This page is a summary of: Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study, PLoS ONE, November 2020, PLOS,
DOI: 10.1371/journal.pone.0241684.
You can read the full text:
Contributors
The following have contributed to this page
